July 29, 2021
We’re taking a long look at two new guidance documents on ethics for HIV prevention trials, one by the HIV Prevention Trials Network (HPTN) and another from UNAIDS/WHO.
Check out Ethical Guidance in Focus, a blog by Jeanne Baron that spotlights what’s new, how the two publications contrast, and implications for advocacy.
And we hope you’ll join next week’s webinar New Ethical Guidelines for HIV prevention trials in people: What’s changed and Why Does it Matter? on Thursday, 5 August at 9am US EDT / 3-4pm Southern Africa / 4-5pm Eastern Africa.
The webinar will explore the guidance documents in-depth, and offer a discussion on the changes and what they mean for HIV prevention research.
Panelists include:
- Catherine Slack, PhD. Head, HIV/AIDS Vaccines Ethics Group, University of KwaZulu-Natal, Pietermaritzburg, South Africa
- Andreas Reis, MD, MSc. Co-Lead, Health Ethics & Governance Unit, WHO, Geneva
- Jeremy Sugarman, MD, MPH, MA. Professor of Bioethics and Medicine, Johns Hopkins University, Baltimore, US, and Chair of the HPTN Ethics Working Group
Looking forward to working with you all on a future for trial design that’s ready for next generation prevention.